Patent Assignment
Reel/Frame 026064/0593
Security Agreement
Recorded: 2011-03-30
Received: 2011-03-30
Pages: 14
Assignor
NORTHROP GRUMMAN SHIPBUILDING, INC.
Executed: 2011-03-30
Assignee
JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
P.O. BOX 2558, LIEN PERFECTION UNIT, HOUSTON, TX, 77252-8301, UNITED STATES
Covered Properties
(82)
Bisphosphonate Compounds
Application:
12/912,514 →
Compositions and Aqueous Dispersions
Application:
12/858,082 →
Compositions Comprising 5-Amino-2-Hydroxybenzoic Acid and a Reducing Sugar
Application:
12/769,293 →
Low Dosage Forms of Risedronate or Its Salts
Application:
12/638,359 →
Dosage Forms of Bisphosphonates
Application:
12/637,100 →
Low Dosage Forms of Risedronate or Its Salts
Application:
12/637,309 →
Corticotropin Releasing Factor 2 Receptor Agonists
Application:
12/605,718 →
Tuned Rolling Wave Energy Extractor
Application:
12/544,616 →
Extended Cycle Multiphasic Oral Contraceptive Kit
Application:
12/534,902 →
Overhead Servicing of Machines
Application:
12/500,360 →
Method of Treatment
Application:
12/397,433 →
Doxycycline Metal Complex in a Solid Dosage Form
Application:
12/338,491 →
Coupling Process for Preparing Quinolone Intermediates
Application:
12/258,480 →
Shock Simulation Generator
Application:
12/248,749 →
Method, Apparatus and Computer Program Product for Fault Protection
Application:
12/245,180 →
Intravaginal Drug Delivery Devices for the Delivery of Macromolecules and Water-Soluble Drugs
Application:
12/147,310 →
Vitamin D Content Uniformity in Pharmaceutical Dosage Forms
Application:
12/148,987 →
Stable Hydrate of a Muscarinic Receptor Antagonist
Application:
12/049,660 →
Portable Multi-Function Machine Tool
Application:
12/019,977 →
Methods to Administer Solid Dosage Forms of Ethinyl Estradiol and Prodrugs Thereof with Improved Bioavailability
Application:
11/955,072 →
Impedance Measurement Using Line-to-Line Current Injection
Application:
11/867,965 →
Pod Propulsion System with Rim-Mounted Bearings
Application:
11/771,175 →
Variable Torque Valve Actuator
Application:
11/766,154 →
Passive Exhaust Suppressor and Method
Application:
11/760,097 →
Blister Card
Application:
29/285,645 →
Extended Cycle Multiphasic Oral Contraceptive Method
Application:
11/704,307 →
Corticotropin Releasing Factor 2 Receptor Agonists
Application:
11/701,576 →
Corticotropin Releasing Factor 2 Receptor Agonists
Application:
11/701,912 →
System and Method for Tensioning and Locking a Safety Strand
Application:
11/567,811 →
Electronically Moderated Expansion Electrical Generator
Application:
11/562,186 →
Derivative Prodrugs of Ethinyl Estradiol
Application:
11/478,582 →
Quadraphasis Continuous Graduated Estrogen Contraceptive
Application:
11/476,675 →
Gel compositions for topical administration
Application:
11/454,717 →
Estrogen compositions for vaginal administration
Application:
11/454,697 →
Methods for Identifying Compounds for Regulating Muscle Mass or Function Using Corticotropin Releasing Factor Receptors
Application:
11/412,025 →
Power Distribution Expert System
Application:
11/351,550 →
Phase Cooling Method and Apparatus
Application:
11/302,705 →
Dosage Forms of Risedronate
Application:
11/286,875 →
Oral Pharmaceutical Products Containing 17BETA-Estradiol-3-Lower Alkanoate, Method of Administering the Same and Process of Preparation
Application:
11/154,704 →
Pharmaceutical Combinations
Application:
11/140,723 →
Corticotropin Releasing Factor 2 Receptor Agonists
Application:
11/121,612 →
Extended Estrogen Dosing Contraceptive Regimen
Application:
11/112,290 →
Dosage Forms of Bisphosphonates
Application:
11/106,816 →
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
Application:
11/096,457 →
Extended Cycle Multiphasic Oral Contraceptive Method
Application:
11/078,300 →
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
Application:
11/070,995 →
Di-Steroidal Prodrugs of Estradiol
Application:
11/009,618 →
Di-Steroidal Prodrugs of Ethinyl Estradiol
Application:
11/009,617 →
Graduated Estrogen Contraceptive
Application:
10/987,653 →
Multi-Spectral Air Inlet Shield and Associated Inlet Structure
Application:
10/958,481 →
Pod Propulsion System with Rim-Mounted Bearings
Application:
10/948,061 →
Passive Exhaust Suppressor and Method
Application:
10/917,212 →
Submersible Lantern
Application:
10/912,347 →
Process for Controlling Crystal Structure of Risedronate
Application:
10/901,692 →
Doxycycline Metal Complex in a Solid Dosage Form
Application:
10/896,045 →
Shock, Vibration and Acoustic Isolation System
Application:
10/850,209 →
Oral Pharmaceutical Products Containing 17BETA-Estradiol-3-Lower Alkanoate, Method of Administering the Same and Process of Preparation
Application:
10/833,997 →
Self-Powering Shock, Vibration and Acoustic Isolation System
Application:
10/662,731 →
Methods for Identifying Compounds for Regulating Muscle Mass or Function Using Corticotropin Releasing Factor Receptors
Application:
10/649,852 →
Stable Hydrate of a Muscarinic Receptor Antagonist
Application:
10/396,887 →
Corticotropin Releasing Factor 2 Receptor Agonists
Application:
10/317,251 →
Corticotropin Releasing Factor 2 Receptor Agonists
Application:
10/315,964 →
Corticotropin Releasing Factor 2 Receptor Agonists
Application:
10/317,252 →
Material Turn Table
Application:
10/265,739 →
Prostaglandin Compositions and Methods of Treatment for Male Erectile Dysfunction
Application:
10/236,485 →
Method of Treating Irritable Bowel Syndrome
Application:
10/218,735 →
System and Method for Loading Stores on an Aircraft
Application:
10/201,085 →
Submersible Lantern
Application:
10/201,058 →
Radiation Shielding
Application:
10/095,023 →
Method and Apparatus for Fastening a Tube to a Wall
Application:
10/037,283 →
Oral Pharmaceutical Products Containing 17 Beta-Estradiol-3-Lower Alkanoate, Method of Administering the Same and Process of Preparation
Application:
10/023,748 →
Pharmaceutical Dosage Form with Multiple Coatings for Reduced Impact of Coating Fractures
Application:
09/996,555 →
Shock and Vibration Isolation Mount with Variable Thickness Support Section
Application:
09/986,355 →
Shock, Vibration and Acoustic Isolation System
Application:
09/963,566 →
Prostaglandin Compositions and Methods of Treatment for Male Erectile Dysfunction
Application:
09/947,617 →
Cascaded Multi-Level H-Bridge Drive
Application:
09/930,249 →
Chewable Oral Contraceptive
Application:
09/879,028 →
Methods for Identifying Compounds for Regulating Muscle Mass or Function Using Corticotropin Releasing Factor Receptors
Application:
09/799,978 →
Welding Rod Extending Assembly for Attachment with Electrode Holder
Application:
09/785,506 →
Controllable Equipment Mount
Application:
09/785,401 →
Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
Application:
09/771,825 →
Process for Making Geminal Bisphosphonates
Application:
09/771,899 →